GVAX cancer vaccine consisting of patient tumor cells engineered to secrete G-CSF data

SOMA announced that results of Phase I/II testing in 50 patients showed safety and a specific

Read the full 161 word article

How to gain access

Continue reading with a
two-week free trial.